What Goes On Inside Your Boardroom? Investors Want To Know
Public M&A Day in Frankfurt
Global Dealmaking in 2013: Why the Best Strategies will Dominate
Dealmakers across Europe were hampered by elevated core inflation rates and a darkening economic outlook in the first half of 2023. The constrained financing environment has put a check on dealmaking activity across the...more
Below is our Corporate / M&A decisions update covering decisions in the fourth quarter of 2022. This update is designed to highlight selected important M&A, corporate, and commercial court decisions on a quarterly basis....more
French deal volume in 2022 remained at historic levels, even while deal values dipped in the final quarter of the year France’s M&A market had a solid run of deal activity in 2022 and continues to demonstrate resilience....more
Although the record-breaking deal activity of 2021 spilled over into 2022, headwinds in the first quarter developed into a significant slowdown during the rest of 2022, with an expectation of continued slowness as we enter...more
Coming off record-setting levels in 2021, M&A deal activity cooled in the second half of 2022. A multitude of factors – including soaring inflation, steadily rising interest rates and the higher cost of financing,...more
After two years of pandemic caution and amid perpetually increasing valuations, growing piles of dry powder and pent-up investment willpower, 2021 exploded in a global deal frenzy unrivaled in the past decade. On the heels of...more
Middle East dealmaking has been trending up steadily over recent years, reaching the highest annual volume on record in 2021. Annual deal value, meanwhile, posted its second highest figure on record, after 2019, with US$120.7...more
Explore the data The headline for the first half of 2022 is that US M&A markets are still remarkably healthy, despite a confluence of headwinds. Without question, 2021 was an exceptional year, fueled by pent-up demand,...more
Companies across the globe are turning to M&A to fulfill their ESG ambitions while investors seek the steep returns on offer - As businesses race to catch up with the global ESG (environmental, social, and governance)...more
Traditionally a powerhouse of European M&A, the DACH region—D for Germany, A for Austria and CH for Switzerland—did not disappoint in the first three quarters of the year. A total of 1,113 announced deals valued at...more
Despite a drop on the previous quarter, Q3 2021 global M&A value represented the strongest Q3 on Mergermarket record - The third quarter is usually a sleepy one for M&A—but not so this year. A total of US$1.4 trillion in...more
An increase in megadeals reveals growing dealmaker appetite within Italy’s M&A market - Dealmaking confidence appears to be returning within the Italian M&A market. A total of US$57.4 billion-worth of deals announced in...more
The region’s burgeoning digital economy is drawing attention from investors across the globe - The value of deals taking place in Southeast Asia reached a new high in the first half of 2021. Deals worth US$101.6 billion...more
After a turbulent 18 months which saw M&A crash before an impressive return to form, H2 2021 is set for continued strong deal activity, as well as new challenges - US M&A progressed steadily through the first half of 2021....more
The value of healthcare M&A in H1 surpassed pre-pandemic levels - Healthcare M&A (including pharma, biotech and medical) saw strong growth over the first half of 2021 as investors continued to pursue deal opportunities in...more
Technology M&A activity is thriving in 2021 as dealmakers continue to turn to the sector in search of assets with high-quality earnings and growth prospects - Technology deal volume and value surged through the first half...more
Automotive and automotive-adjacent M&A sees fourth consecutive quarterly rise in value, supported by strong SPAC interest in electric vehicles - Looking at automotive sector M&A, you would think the pandemic had never...more
Dealmaking within the PMB sector enjoyed an impressive start as companies across the globe embarked on their post-pandemic recovery - The global pharma, medical and biotech (PMB) sector saw US$95.4 billion in deal...more
US M&A Outlook: Rebounding Market Fuels Optimism for Deal Activity in 2021 - The U.S. M&A market faced unprecedented challenges in 2020 as a result of the COVID-19 pandemic. Dealmaking returned in full force by the end of...more
Welcome to the Akin Gump Global Private Equity/M&A Survey 2021: Opportunities Ahead. The last 12 months have been hugely challenging for dealmakers around the world but, after an initial period of disruption following...more
After nearly a decade of growth, global M&A activity in the first quarter of 2020 was down 39.1% by deal value year over year — comparable to levels seen in the first quarter of 2008, in the midst of the financial crisis. The...more